QuantiGene cancer and disease research assay kits

Thursday, 10 March, 2011 | Supplied by: Millennium Science Pty Ltd


QuantiGene cancer and disease research assay kits enable direct quantification of miRNA, mRNA or DNA targets directly from any sample. They are based on the branched DNA (bDNA) signal amplification technology used in Siemens’ FDA-approved Versant assays for HIV and Hepatitis C viral load testing.

Each kit contains everything needed to detect and quantify or view genes or transcripts of interest. Simply provide the accession number or sequence information for those genes or transcripts and Affymetrix will generate the necessary probe sets to be used in each assay kit.

The assays deliver unparalleled flexibility in three formats: ViewRNA for applications involving expression heterogeneity, infectious diseases, stem cells and differentiation, miRNA analysis, cancer tissue analysis; 2.0 to validate microarray results, quantify siRNA knockdowns, quantify DNA copy number, quantify miRNAs, detect translocations and fusion genes; and Plex for gene signatures, pathway analysis, DNA copy number analysis and biomarker detection in clinical samples.

Online: www.mscience.com.au
Phone: 03 8561 9000
Related Products

Abcam knockout cell lines, lysates and pellets

Abcam's knockout (KO) catalogue range and custom service makes it easy for scientists to get...

Echelon Biosciences PIP Mass Assays

Developed by Echelon Biosciences, PIP Mass Assays offer researchers a comprehensive selection of...

Aviva Systems Biology Protein on Demand semi-custom recombinant proteins

Protein on Demand allows users to semi-customise the tag and expression system used to produce...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd